Seroepidemiological Study of Pertussis and Other Infectious Diseases
|ClinicalTrials.gov Identifier: NCT01929473|
Recruitment Status : Completed
First Posted : August 28, 2013
Results First Posted : July 12, 2016
Last Update Posted : July 12, 2016
Serum samples will be corrected twice from the same youth subjects with one year interval.
Seroincidence of pertussis will be estimated by the elevation of Ig-G-PT in paired sera from an identical individual.
The relationship between the incidence and the demographic data or medical history of the subjects will be discussed.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||3830 participants|
|Official Title:||Seroepidemiological Study of Pertussis and Other Infectious Diseases|
|Study Start Date :||September 2013|
|Actual Primary Completion Date :||November 2014|
|Actual Study Completion Date :||November 2014|
- IgG [ Time Frame: 0 day, 365 day (2 points) ]Seroincidence of pertussis estimated by the elevation of Ig-G-PT in paired sera(0day, 365day).
- Incidence of Pertussis [ Time Frame: 0 day ]Questionnaire
- Antibodies of Varicella, Mumps and Rubella [ Time Frame: 0 day ]Questionnaire
- Infection Risk Factors Including Family Numbers, Living Space, With or Without a Cough Patient in the Surroundings, Medical History and Hospitalization [ Time Frame: 365 day ]Questionnaire
Biospecimen Retention: Samples Without DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01929473
|Study Chair:||Naoki Kawai||Gifu Prefecture Medial Association|